Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: October 15, 2025

  • Open
    75.29
  • High
    78.15
  • Low
    75.29
  • Close
    77.68
  • Volume
    1,149,580

Financial ratios

Dec 31, 2024